| 932042-85-8 Basic information More.. |
Product Name: | β-(BenzoylaMino)-α-hydroxybenzenepropanoic Acid (αR,βS)-(1S,3S,4S,4aR,5S,6S,8S,11R,12aS)-3,11-Bis(acetyloxy)-4-[(benzoyloxy)Methyl]-1,2,3,4,4a,5,6,7,8,11,12,12a-dodecahydro-1,4,5,6-tetrahydroxy-9,12a,13,13-tetraMethyl-12-oxo-6,10-Methanobenzocyclodecen-8- | Synonyms: | Paclitaxel Oxetane Ring-Opened 3-Acetyl 4-Benzoyl IMpurity;β-(BenzoylaMino)-α-hydroxybenzenepropanoic Acid (αR,βS)-(1S,3S,4S,4aR,5S,6S,8S,11R,12aS)-3,11-Bis(acetyloxy)-4-[(benzoyloxy)Methyl]-1,2,3,4,4a,5,6,7,8,11,12,12a-dodecahydro-1,4,5,6-tetrahydroxy-9,12a,13,13-tetraMethyl-12-oxo-6,10-Methanobenzocyclodecen-8-yl Ester;Paclitaxel Impurity 13(Paclitaxel EP Impurity M);Paclitaxel EP Impurity M
1,2α,4,7β-dihydroxy-9-oxotax-11-ene-5β,10β,13α,20- tetrayl 5,10-diacetate 20-benzoate 13-[(2R,3S)-3- (benzoylamino)-2-hydroxy-3-phenylpropanoate;1,2α,4,7β-dihydroxy-9-oxotax-11-ene-5β,10β,13α,20- tetrayl 5,10-diacetate 20-benzoate 13-[(2R,3S)-3- (benzoylamino)-2-hydroxy-3-phenylpropanoate;Benzenepropanoic acid, β-(benzoylamino)-α-hydroxy-, (1S,3S,4S,4aR,5S,6S,8S,11R,12aS)-3,11-bis(acetyloxy)-4-[(benzoyloxy)methyl]-1,2,3,4,4a,5,6,7,8,11,12,12a-dodecahydro-1,4,5,6-tetrahydroxy-9,12a,13,13-tetramethyl-12-oxo-6,10-methanobenzocyclodecen-8-yl ester, (αR,βS)-;(1S,3S,4S,4aR,5S,6S,8S,11R,12aS)-3,11-Bis(acetyloxy)-4-[(benzoyloxy)methyl]-1,2,3,4,4a,5,6,7,8,11,12,12a-dodecahydro-1,4,5,6-tetrahydroxy-9,12a,13,13-tetramethyl-12-oxo-6,10-methanobenzocyclodecen-8-yl(αR,βS)-β-(benzoylamino)-α-hydroxybenzenepropanoate;Paclitaxel EP Impurity M
1,2α,4,7β-dihydroxy-9-oxotax-11-ene-5β,10β,13α,20- tetrayl 5,10-diacetate 20-benzoate 13-[(2R,3S)-3- (benzoylamino)-2-hydroxy-3-phenylpropanoate] | CAS: | 932042-85-8 | MF: | C47H53NO15 | MW: | 871.92 | EINECS: | | Mol File: | Mol File | |
|
932042-85-8 Recommend
Suppliers |
|
|
Recommend You Select Member Companies. |
|
|